Black Diamond Therapeutics and Ideaya Biosciences are mulling over registrational trials for their lead assets after ...

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) reported initial Phase 2 data of BDTX-1535. The data demonstrated encouraging ...

Black Diamond Therapeutics, Inc. (BDTX) announced positive initial Phase 2 results for BDTX-1535 in patients with relapsed or ...

Shares in Black Diamond Therapeutics rose after the company outlined positive initial data from Phase 2 trials of BDTX-1535, an oral cancer treatment. Shares were up 46% in premarket trading at $6.94.

Webcast to be held Monday, September 23, at 8:00 a.m. ET CAMBRIDGE, Mass., Sept. 22, 2024 (GLOBE NEWSWIRE) -- . (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that ...

Black Diamond Therapeutics (NASDAQ:BDTX) reported encouraging Phase 2 data for its drug candidate BDTX-1535 in the treatment ...

Emma Coronel, the wife of El Chapo, walked the runway yesterday, Sunday, September 22, in Milan in a wedding dress for April ...

Neal Brown, who is coming off of a 9-win campaign in 2023, will have to find four more wins if he hopes for his team to ...

In his essay The Superinvestors of Graham-and-Doddsville Warren Buffett described how share prices do not always rationally ...

Raymond James has recently initiated Black Diamond Therapeutics Inc (BDTX) stock to Outperform rating, as announced on July 31, 2024, according to Finviz. Earlier, on July 14, 2023, Piper Sandler had ...

Black Diamond Therapeutics (BDTX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Robert Burns from H.C. Wainwright reiterated a Buy rating on ...

Black Diamond’s Traverse 3 poles are simplicity refined. The Traverse 3 is a 125cm touring pole in 3 sections, a magical ...